Trinity Biotech plc
TRIB
$0.35
$0.000.91%
NASDAQ
| 12/31/2025 | 06/30/2025 | 12/31/2024 | 09/30/2024 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | -32.35% | 28.89% | -308.36% |
| Total Depreciation and Amortization | -- | -- | -61.92% | -2.16% | -34.30% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | 61.85% | -42.68% | 49.89% |
| Change in Net Operating Assets | -- | -- | 251.32% | 98.25% | -288.38% |
| Cash from Operations | -- | -- | 63.73% | 26.76% | -92.69% |
| Capital Expenditure | -- | -- | 49.56% | 51.56% | -150.46% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -100.00% | -- |
| Other Investing Activities | -- | -- | -687.02% | -614.16% | 49.93% |
| Cash from Investing | -- | -- | -192.78% | -186.18% | 25.74% |
| Total Debt Issued | -- | -- | 503.52% | 463.39% | 5,569.78% |
| Total Debt Repaid | -- | -- | 79.77% | 80.73% | -3,934.90% |
| Issuance of Common Stock | -- | -- | -- | 1,772.89% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 24.81% | 11.49% | -433.43% |
| Cash from Financing | -- | -- | 279.60% | 260.97% | -245.58% |
| Foreign Exchange rate Adjustments | -- | -- | -297.73% | -263.27% | 115.32% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | 151.13% | -244.51% | -367.26% |